Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_4C2D9AD34505
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma.
Journal
European journal of cancer
Author(s)
Tétu P., Mangana J., Dummer R., Dutriaux C., Beneton N., Dalle S., Meyer N., Oriano B., Michielin O., Lebbe C.
ISSN
1879-0852 (Electronic)
ISSN-L
0959-8049
Publication state
Published
Issued date
04/2018
Peer-reviewed
Oui
Volume
93
Pages
147-149
Language
english
Notes
Publication types: Letter ; Multicenter Study
Publication Status: ppublish
Keywords
Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Follow-Up Studies, Humans, Ipilimumab/administration & dosage, Melanoma/drug therapy, Melanoma/pathology, Nivolumab/administration & dosage, Prognosis, Retrospective Studies, Survival Rate
OAI-PMH
oai:serval.unil.ch:BIB_4C2D9AD34505
DOI
10.1016/j.ejca.2018.01.062
Pubmed
29449059
Web of science
000428617300018
Create date
01/03/2018 21:46
Last modification date
20/08/2019 15:00
Usage data